Collate
Summary active Updated Jun 3, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Investors
Founders
About
Collate is a San Francisco-based AI platform that automates documentation for life sciences companies, generating and maintaining the regulatory filings, clinical trial paperwork, and product-development records that diagnostics, medical device, and drug development companies must produce from concept through market launch 123. The company was co-founded by Surbhi Sarna (former Y Combinator partner and founder of nVision Medical, acquired by Boston Scientific for $275M in 2018), Nate Smith (co-founder of recruiting platform Lever and former YC visiting partner), and Jigish Patel 24. Collate emerged from stealth in January 2025 with a $30M seed round and, roughly 17 months later, raised a $95M Series B led by Redpoint Ventures at a valuation approaching $1B, bringing total funding to $125M 12. The company reports 50+ customers including large pharmaceutical and medical device companies 3.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-06-03 | Series B | $95M | Redpoint Ventures | 123 |
| 2025-01-21 | Seed | $30M | Redpoint Ventures | First Round Capital, Conviction Partners, Y Combinator 45 |
What Investors Say
No independently sourced investor quotes found at this time.
What Founders Say
Surbhi Sarna, CEO and Co-Founder, told Forbes: “Life sciences strategy and documentation is going to be the AI battleground of 2026, the same way it was for legal in 2025.” 12
Sources
-
RamaOnHealthcare, “AI Startup Collate Raises $95 Million To Automate Life Sciences Paperwork,” June 3, 2026. Accessed June 2026. https://ramaonhealthcare.com/ai-startup-collate-raises-95-million-to-automate-life-sciences-paperwork/↩↩↩↩
-
Forbes (via @Forbes on X), “AI Startup Collate Raises $95 Million To Automate Life Sciences Paperwork,” June 3, 2026. Accessed June 2026. https://x.com/Forbes/status/206227827800694005↩↩↩↩↩
-
Wall St Engine on X, summarizing Forbes coverage of Collate’s $95M Series B led by Redpoint at ~$1B valuation, June 3, 2026. Accessed June 2026. https://x.com/wallstengine/status/2062251479784882439↩↩↩
-
American Bazaar, “Biotech startup Collate secures $30 million seed fund to automate paperwork,” January 21, 2025. Accessed June 2026. https://americanbazaaronline.com/2025/01/21/biotech-startup-collate-secures-30-million-seed-fund-to-automate-paperwork458548/↩↩
-
Surbhi Sarna on X, announcing Collate and its $30M seed round, January 13, 2025. Accessed June 2026. https://x.com/SurbhiSarnaSF/status/1878884972909781119↩